A review of the existing evidence to date on the management of prostate cancer in the older population was published online July 28 as part of a special issue of the Journal of Clinical Oncology devoted to geriatric oncology.
Underlying health status and age-related changes can have an effect on tolerance of hormonal therapy and chemotherapy in men with advanced disease, said Dr. Chunkit Fung of the University of Rochester (N.Y.) and his associates.
They recommend using common geriatric assessment tools to categorize men into "stages of age" to assist with decision making. They used this framework – categorizing men as fit, vulnerable, and frail – to provide an evidence-based guide to the management of older men with prostate cancer, with a focus on systemic disease. The review is available on the journal’s website here.
lnikolaides@frontlinemedcom.com
On Twitter @nikolaideslaura